Protagenic Therapeutics (PTIX) said Tuesday that it has struck a deal to sell about 1.95 million shares, series A warrants and series B warrants to raise about $1.275 million for working capital.
The purchase price of each share and associated warrants will be $0.64, the firm said. It expects to close the offering Nov 4, with Brookline Capital Markets, a division of Arcadia Securities, as the placement agent.
The stock was down more than 10% in recent trading.
Price: 0.57, Change: -0.07, Percent Change: -10.49
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。